Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma

NCT02549833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Oligodendroglioma
Astrocytoma, Grade II
Glioma, Astrocytic
Glioma
Malignant Glioma
Oligoastrocytoma, Mixed

Interventions

BIOLOGICAL: GBM6-AD and poly-ICLC before and after surgery
BIOLOGICAL: GBM6-AD and poly-ICLC after surgery only

Sponsor

Jennie Taylor

Collaborators

[object Object]